Photodynamic therapy of superficial nasal planum squamous cell carcinomas in cats: 55 Cases

Journal of Veterinary Internal Medicine

Volumn 22, Issue 6, 2008, Pages 1385-1389

  Bexfield, Nicholas H ^a   Stell, A J ^b   Gear, R N ^a   Dobson, J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

5 aminolaevulinic acid; PDT; Photosensitizer; Skin tumor; Treatment

Indexed keywords

AMINOLEVULINIC ACID; RADIOSENSITIZING AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CLINICAL TRIAL; NOSE TUMOR; PHOTOCHEMOTHERAPY; SQUAMOUS CELL CARCINOMA;

AMINOLEVULINIC ACID; ANIMALS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; NOSE NEOPLASMS; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS;

ANIMALIA; FELIDAE;

EID: 57149105140     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0186.x     Document Type: Article

References (37)

1. Dorn CR. Epidemiology of canine and feline tumours. J Am Anim Hosp Assoc 1976;12:307-312.
2. Owen LN. TNM Classification of Tumours in Domestic Animals. Geneva: World Health Organisation; 1980.
3. Withrow SJ, Straw RC. Resection of the nasal planum in nine cats and five dogs. J Am Anim Hosp Assoc 1990;26:219-222.
4. Carlisle CH, Gould S. Response of squamous cell carcinoma of the nose of the cat to treatment with X rays. Vet Radiol Ultrasound 1982;23:186-192.
5. Théon AP, Madwell BR, Shearn VI, Moulton JE. Prognostic factors associated with radiotherapy of squamous cell carcinoma of the nasal plane in cats. J Am Vet Med Assoc 1995;206:991-996.
6. Grier RL, Brewer WG, Theilen GH. Hyperthermic treatment of superficial tumours in cats and dogs. J Am Vet Med Assoc 1980;177:227-233.
7. Théon AP, VanVechten MK, Madewell BR. Intratumoral administration of carboplatin for treatment of squamous cell carcinomas of the nasal plane in cats. Am J Vet Res 1996;57:205-210.
8. 90strontium plesiotherapy for feline squamous cell carcinoma of the nasal planum. J Feline Med Surg 2006;8:169-176.
9. Roberts WG, Klein MK, Loomis M, et al. Photodynamic therapy of spontaneous cancers in felines, canine and snakes with chloro-aluminum sulfonated phthalocyanine. J Natl Cancer Inst 1991;83:18-23.
10. Peaston AE, Leach MW, Higgins RJ. Photodynamic therapy for nasal and aural squamous cell carcinoma in cats. J Am Vet Med Assoc 1993;202:1261-1265.
11. Magne ML, Rodriguez CO, Autry SA, et al. Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer. Lasers Surg Med 1997;20:202-209.
12. Hahn KA, Panjehpour M, Legendre AM. Photodynamic therapy response in cats with cutaneous squamous cell carcinomas as a function of fluence. Vet Dermatol 1998;9:3-7.
13. Stell AJ, Dobson JM, Langmack K. Photodynamic therapy of feline superficial squamous cell carcinoma using topic 5-aminolaevulinic acid. J Small Anim Pract 2001;42:164-169.
14. Buchholz J, Wergin M, Walt H, et al. Photodynamic therapy of feline cutaneous squamous cell carcinoma using a newly developed liposomal photosensitizer: Preliminary results concerning drug safety and efficacy. J Vet Intern Med 2007;21:770-775.
15. Lucroy MD, Edwards BF, Peavy GM, et al. Preclinical study in cats of the pro-photosensitizer 5-aminolaevulinic acid. Am J Vet Res 1999;60:1364-1370.
16. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-148.
17. Garcia-Zuazaga J, Cooper KD, Baron ED. Photodynamic therapy in dermatology: Current concepts in the treatment of skin cancer. Expert Rev Anticancer Ther 2005;5:791-800.
18. Lana SE, Oglivie GK, Withrow SJ. Feline cutaneous squamous cell carcinoma of the nasal planum and pinnae: 61 cases. J Am Anim Hosp Assoc 1997;33:329-332.
19. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;457-481.
20. Lui H, Salasche S, Ariz T, et al. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: A clinical and histological study. Arch Dermatol 1995;131:737-738.
21. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000;42:389-413.
22. Cappugi P, Campolni P, Mavilio L, et al. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology; a minireview. J Chemother 2001;13:494-499.
23. Salim A, Lemen JA, McColl JH, et al. Randomized comparison of photodynamic therapy with topical 5-fluoruracil in Bowen's disease. Br J Dermatol 2003;148:539-543.
24. Peng Q, Berg K, Moan J, et al. 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem Photobiol 1997;65:235-251.
25. Egli RJ, Schober M, Hempfing A, et al. Sensitivity of osteoblasts, fibroblasts, bone marrow cells and dendritic cells to 5-aminolevulinic acid based photodynamic therapy. J Photochem Photobiol B 2007;89:70-77.
26. Clark C, Bryden A, Dawe R, et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: Outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003;19:134-141.
27. Gibson SL, Meid KRvd, Murant RS, et al. Effects of various photoradiation regimes on the antitumour efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res 1990;50:7236-7241.
28. Pierre MB, Ricci E Jr, Tedesco AC, Bentley MV. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm Res 2005;23:360-366.
29. Moan J, Iani V, Ma LW. Choice of the proper wavelength for photochemotherapy. Proc Soc Photo Opt Instrum Eng 1996;2625:544-549.
30. Radakovic-Fijan S, Blecha-Thalhammer U, Kittler H, et al. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: A randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 2005;53:823-827.
31. Sitnik TM, Henderson BW. The effect of fluence rate on tumour and normal tissue responses to photodynamic therapy. Photochem Photobiol 1998;67:462-466.
32. McCarron PA, Donnelly RF, Zawislak A, Woolfson AD. Design and evaluation of a water-soluble bioadhesive patch formulation of cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions. Eur J Pharm Sci 2006;27:268-279.
33. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989;259:315-324.
34. de Groot DJA, de Vries EGE, Groen HJM, de Jong S. Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic. Crit Rev Oncol Hematol 2007;61:52-69.
35. Akita Y, Kozaki K, Nakagawa A, et al. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity. Br J Dermatol 2004;151:472-480.
36. Ferrario A, Fisher AM, Rucker N, Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 2005;65:9473-9478.
37. Hayes A, Scase T, Miller J, et al. COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J Comp Pathol 2006;135:93-99.